Brian R. Adams's most recent trade in Kymera Therapeutics Inc was a trade of 3,025 Common Stock done at an average price of $116.8 . Disclosure was reported to the exchange on Sept. 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 116.81 per share. | 04 Sep 2026 | 3,025 | 52,391 | - | 116.8 | 353,350 | Common Stock |
| Kymera Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 117.57 per share. | 04 Sep 2026 | 2,137 | 50,254 | - | 117.6 | 251,247 | Common Stock |
| Kymera Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 115.55 per share. | 04 Sep 2026 | 1,209 | 55,416 | - | 115.6 | 139,700 | Common Stock |
| Kymera Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | 02 Mar 2026 | 8,250 | 8,250 | - | - | Stock Option (Right to Buy) | ||
| Kymera Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 4,125 | 56,625 | - | 0 | Common Stock | |
| Kymera Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | 03 Sep 2025 | 105,000 | 105,000 | - | - | Stock Option (Right to Buy) | ||
| Kymera Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2025 | 52,500 | 52,500 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 3.68 per share. | 28 Jul 2025 | 18,276 | 371,472 | - | 3.7 | 67,256 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 3.74 per share. | 28 Jul 2025 | 1,637 | 389,748 | - | 3.7 | 6,122 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 3.00 per share. | 28 Apr 2025 | 12,943 | 391,385 | - | 3 | 38,829 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 3.17 per share. | 28 Apr 2025 | 1,644 | 404,328 | - | 3.2 | 5,211 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 2.84 per share. | 27 Mar 2025 | 298 | 405,972 | - | 2.8 | 846 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 139,141 | 427,061 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 4.63 per share. | 28 Jan 2025 | 33,688 | 287,920 | - | 4.6 | 155,975 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 4.42 per share. | 28 Jan 2025 | 20,791 | 406,270 | - | 4.4 | 91,896 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | 10 Jan 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | ||
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 4.38 per share. | 27 Dec 2024 | 299 | 321,608 | - | 4.4 | 1,310 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 6.06 per share. | 28 Oct 2024 | 1,632 | 321,907 | - | 6.1 | 9,890 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.51 per share. | 27 Sep 2024 | 295 | 323,539 | - | 7.5 | 2,215 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.85 per share. | 29 Jul 2024 | 1,638 | 323,834 | - | 8.8 | 14,496 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 27 Jun 2024 | 295 | 325,472 | - | 6.3 | 1,847 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 6.38 per share. | 29 Apr 2024 | 1,623 | 325,767 | - | 6.4 | 10,355 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.70 per share. | 27 Mar 2024 | 348 | 327,390 | - | 7.7 | 2,680 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 9.64 per share. | 29 Jan 2024 | 1,929 | 327,738 | - | 9.6 | 18,596 | Common Stock |
| Relay Therapeutics Inc | Mr. Brian R. Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 200,000 | 329,667 | - | 0 | Common Stock |